AI assistant
RESMED INC — Director's Dealing 2011
Nov 18, 2011
30071_dirs_2011-11-18_e640d42e-5ab3-4ccf-b379-cf7979a75e4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-15
Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-11-15 | ResMed Common Stock | G | 200000 | — | Acquired | 726959 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-16 | ResMed Common Stock Options | $27.58 | A | 250000 | Acquired | 2018-11-16 | ResMed Common Stock (250000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 3317 | Indirect |
| ResMed Common Stock | 21391 | Indirect |
| ResMed Common Stock | 0 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Transaction represents a distribution from the Peter C. Farrell November 2010 Annuity Trust (the "Trust") of 200,000 shares to the Peter C. Farrell Trust (of which Dr. Farrell is the Trustee). Per the terms of the trust, 90% of the original value was to be transferred to Dr. Farrell at the end of the first year. Since the value of the stock on the funding date was higher than the current stock price, 100% of the stock was distributed.
F2: Represents date options first become available. Options vest 1/4 annually until fully vested.